Welcome to the December 2012 issue of Pharmaceutical Technology Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, 2012 in review, with a analysis of key events shaping the pharmaceutical industry this year, including approvals of new molecular entities and biologics. And the latest developments from the bio/pharmaceutical industry relating to corporate social responsibility and sustainability.

Global Feature
2012: The Year in Review
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
As this year comes to a close, a look at the key events shaping the pharmaceutical and biopharmaceutical industry in 2012 and what may be on the horizon for 2013.

APIs
The Class of 2012 for New Molecular Entities and Biologics
As 2012 comes to a close, Pfizer leads among Big Pharma companies for FDA approvals of new molecular entities and biologics.
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management.

Outsourcing
Creating a Holistic Procurement System
Gregg Brandyberry is senior vice-president of FedBid, and formerly senior advisor for A.T. Kearney Procurement and Analytic Solutions
The procurement organization rethinks sourcing for maximum efficiency and results.

CSR and SUSTAINABILITY FORUM
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

Advancing Sustainable Packaging
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
MeadWestvaco is recognized at CPhI for its sustainable pharmaceutical packaging.